Peripheral Arterial Disease Biomarkers - Trial NCT06373302
Access comprehensive clinical trial information for NCT06373302 through Pure Global AI's free database. This phase not specified trial is sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Norfolk and Norwich University Hospitals NHS Foundation Trust
Timeline & Enrollment
N/A
May 01, 2024
Dec 31, 2026
Primary Outcome
Correlation between PAD biomarker levels and walking distance.,Change in PAD biomarker levels following exercise therapy.,Change in PAD biomarker levels following endovascular intervention
Summary
The study aims to determine how expression levels of biomarkers for peripheral arterial
 disease change over time in response to exercise therapy, surgical or endovascular
 intervention, and whether they can be used to predict disease progression.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06373302
Non-Device Trial